Sangamo Biosciences (SGMO)
NASDAQ:SGMO
Holding SGMO?
Track your performance easily

Sangamo Biosciences (SGMO) Financial Statements

1,793 Followers

Sangamo Biosciences Financial Overview

Sangamo Biosciences's market cap is currently ―. The company's EPS TTM is $-1.376; its P/E ratio is -0.61; Sangamo Biosciences is scheduled to report earnings on October 31, 2024, and the estimated EPS forecast is $-0.01. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 356.00K$ 481.00K$ 2.04M$ 9.40M$ 6.83M
Gross Profit$ 356.00K$ 481.00K$ 2.04M$ 9.40M$ 6.83M
EBIT$ -36.05M$ -48.99M$ -61.76M$ -102.89M$ -120.77M
EBITDA$ -33.21M$ -46.74M$ -58.75M$ -95.64M$ -115.41M
Net Income Common Stockholders$ -36.13M$ -49.09M$ -60.30M$ -104.19M$ -114.51M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 27.79M$ 54.42M$ 81.00M$ 132.11M$ 143.10M
Total Assets$ 93.01M$ 128.96M$ 165.32M$ 219.70M$ 325.07M
Total Debt$ 29.10M$ 30.82M$ 33.52M$ 34.98M$ 36.37M
Net Debt$ 1.31M$ -23.60M$ -47.49M$ -97.14M$ -106.73M
Total Liabilities$ 69.32M$ 72.26M$ 82.43M$ 84.78M$ 91.43M
Stockholders Equity$ 23.69M$ 56.70M$ 82.89M$ 134.92M$ 233.66M
Cash Flow-
Free Cash Flow$ -26.76M$ -48.66M$ -53.21M$ -50.04M$ -66.25M
Operating Cash Flow$ -26.88M$ -48.66M$ -50.54M$ -47.29M$ -60.71M
Investing Cash Flow$ 127.00K$ 35.84M$ 37.71M$ 37.63M$ 42.47M
Financing Cash Flow$ -533.00K$ 22.12M$ 167.00K$ -100.00K$ 6.52M
Currency in USD

Sangamo Biosciences Earnings and Revenue History

Sangamo Biosciences Debt to Assets

Sangamo Biosciences Cash Flow

Sangamo Biosciences Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis